Skip to:

Mark Litwin

Mark Litwin photo
Professor

Departments

DepartmentsType of Faculty
Health Policy and ManagementPart Time
Contact Information
Phone: 
310.794.8113
Fax: 
310.206.5343

300 Stein Plaza, Suite 300, Los Angeles, CA 90095

Areas of Interest: 
  • Quality of Care
  • Medical Outcomes
  • Health-Related Quality of Life
  • Resource Use
  • Urological Diseases
  • Prostate Cancer        

Mark S. Litwin is chair of the Department of Urology, a practicing urologic oncologist, and professor of urology, health policy & management, and nursing at UCLA.  Dr. Litwin is a translational population scientist who teaches and conducts research in quality of care, health-related quality of life, medical outcomes, medical decision-making, costs and resource utilization, patient preferences, and health care access. He published the first validated quality-of-life instrument to track outcomes in men with prostate cancer and has been an international leader in this area. His research has been funded by the NIDDK, NCI, Department of Defense, American Cancer Society, California Department of Public Health, and other organizations. He has been continuously NIH-funded since 1997. His current projects include a $109 million award to provide prostate cancer care to low-income, uninsured men in California, established in 2001. For 14 years he led Urologic Diseases in America, a $24 million epidemiologic study funded by the NIDDK. He is PI of an innovative T32 program to train fellows in patient-centered outcomes research in urologic and gynecologic oncology. Dr. Litwin received the AUA Gold Cystoscope for his foundational work in establishing the discipline of urological health services research. He also received the AUA Foundation’s Distinguished Mentor Award, the AUA Distinguished Service Award, and the Barringer Medal from the American Association of Genitourinary Surgeons. He teaches in the Schools of Medicine and Public Health and practices urologic oncology at UCLA.

Education: 
MPH, UCLA
MD, Emory University
BS, Duke University
Selected Publications: 

Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH: Quality of life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-135.

Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH.  The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure.  Med Care 1998; 36: 1002-1112.

Litwin MS: Health-related quality of life in older men without prostate cancer.  J Urol 1999; 161: 1180-1184.

Litwin MS, McNaughton-Collins MM, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O’Leary MP: The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI): Development and validation of a new outcome measure.  J Urol 1999; 162; 369-375.

Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG.  Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer.  Urology 2000; 56: 899-905.

Litwin MS, Lubeck DP, Stoddard ML, Pasta DJ, Flanders SC, Henning JM.  Quality of life before death in men with prostate cancer: results from the CaPSURE database.  J Urol 2001; 165: 871-875.

Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS.  The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer.  J Clin Epidiol 2001; 54: 350-358.

McNaughton Collins M, O’Leary MP, Calhoun EA, Pontari MA, Adler A, Eremenco S, Chang CH, Odom L, Litwin MS. The Spanish NIH-Chronic Prostatitis Symptom Index: translation and linguistic validation.  J Urol 2001; 166; 1800-1803.

Saigal CS, Gornbein J, Litwin MS. Stability of time tradeoff utilities for health states associated with the treatment of prostate cancer. Qual Life Res 2002; 11: 405-414.

Saigal CS, Litwin MS.  The economic costs of early stage prostate cancer.  Pharmacoeconomics 2002; 20: 869-878.

Spencer BA, Steinberg M, Malin J, Adams J, Litwin MS.  Quality of care indicators for early stage prostate cancer.  J Clin Oncol 2003; 21: 1928-1936.

Maliski SL, Clerkin B, Litwin MS.  Describing a nurse case manager intervention to empower low-income men with prostate cancer.  Oncol Nurs Forum 2004; 31: 57-64.

Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, Joyce GF, Madison R, Pace J, Polich SM, Wang M. Urologic Diseases in America: analytic methods and principal findings.  J Urol 2005; 173: 933-937.

Krupski TK, Fink A, Kwan L, Maliski SL, Connor S, Clerkin B, Litwin MS. Health-related quality of life in low-income, uninsured men with prostate cancer.  J Health Care Poor Underserved 2005; 16: 375-390.

Gore JL, Kwan L, Saigal CS, Litwin MS. Marriage and mortality in bladder cancer. Cancer 2005; 104: 1188-1194.

Krupski TL, Kwan L, Afifi A, Litwin MS. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol 2005; 23: 7881-7888.

McNaughton-Collins M, Wang Y, Propert KJ, Alexander R, Calhoun E, Nickel JC, O’Leary MP, Pontari M, Litwin MS.  Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006; 15: 299-305. 

Anger JT, Maliski, SL, Krupski L, Kwan L, Gore JL, Fink A, Connor SE, Orecklin JR, Litwin MS. Outcomes in men denied access to a California public assistance program for prostate cancer. Pub Health Rep 2007; 122: 217-223.

Miller DC, Spencer BA, Wei JT, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Litwin MS. Treatment choice and quality of care for men with localized prostate cancer. Med Care 2007; 45: 401-409.

Litwin MS, Gore J, Kwan L, Brandeis JM, Lee SP, Withers HR, Reiter RE. Quality of life following surgery, external beam irradiation, or brachytherapy for early stage prostate cancer.  Cancer 2007; 109: 2239-2247.

Litwin MS, Greenfield S, Elkin EP, Lubeck DP, Broering JM, Kaplan SH. Assessment of prognosis with the Total Illness Burden Index for Prostate Cancer (TIBI-CaP): validation of an instrument to aid clinicians in treatment choice. Cancer 2007; 109: 1777-1783.

Zavala MW, Maliski SL, Kwan L, Miller DC, Fink A, Litwin MS.  Longitudinal quality of life in low-income men in a state-funded prostate cancer treatment program. J Health Care Poor Underserved 2008; 19: 200-214. 

Miller DC, Saigal CS, Banarjee M, Hanley J, Litwin MS. Diffusion of surgical innovation among patients with kidney cancer.  Cancer 2008; 112: 1708-1717.  PMCID:  PMC2650731.

Maliski SL, Kwan L, Elashoff D, Litwin MS. Symptom clusters related to prostate cancer treatment. Oncol Nurs Forum 2008; 35: 786-793.

Spencer BA, Miller DC, Litwin MS, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Wei JT. Variations in quality of care for men with early-stage prostate cancer.  J Clin Oncol 2008; 26: 3735-3742.

Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters L, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate cancer survivors and their spouses. N Engl J Med 2008; 358: 1250-1261.

Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Nat Cancer Inst 2009; 101: 888-892.

Bergman J, Saigal CS, Kwan L, Litwin MS. Responsiveness of the UCLA Prostate Cancer Index. Urol 2010; 74: 1418-1423.

Maliski SL, Williams L, Connor SE, Litwin MS. Faith among low-income, African-American men treated for prostate cancer. Cancer Nursing 2010; 33: 470-478.

Daskivich T, Sadetsky N, Kaplan SH, Greenfield S, Litwin MS.  Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Int Med 2010; 170: 1396-1397.

Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A, Greenfield S, Litwin MS. Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer 2011; 117: 2058-2066.

Bergman J, Fink A, Kwan L, Maliski S, Litwin MS. Spirituality and end of life care in disadvantaged men dying of prostate cancer. World J Urol 2011; 29: 43-49.

Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS. Quality of care in patients with bladder cancer: a case report? Cancer 2012; 118: 1412-1421.

Chamie K, Daskivich TJ, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS. Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Int Med 2012; 27: 492-499.

Chamie K, Connor SE, Maliski SL, Fink A, Kwan L, Litwin MS. Prostate cancer survivorship: lessons from caring for the uninsured. Urol Oncol 2012; 30: 102-08.

Yiee J, Chang L, Kaplan A, Kwan L, Chung P, Litwin MS. Patterns of care in testicular torsion: influence of hospital transfer on testicular outcomes. J Ped Urol 2013; 9: 713-720.

Scales CD, Hanley LM, Dick A, Setodji C, Saigal CS, Litwin MS. The impact of unplanned post-procedure visits in the management of patients with urinary stones. Surgery 2014; 155: 769-765.

Bergman J, Saigal C, Litwin MS. Service intensity and physician income: conclusions from Medicare's physician data release. JAMA Int Med 2015; 175: 297-299.

Scales CD, Bergman J, Carter S, Jack G, Saigal C, Litwin MS. Quality of acute care for patients with kidney stones in the United States. Urology 2015; 86: 914-921.

Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer. JAMA 2017; 317: 2532-2542.

Nabhani J, Vargas GB, Kwan L, Connor SE, Fink A, Maliski SL, Litwin MS. The experience of low-income men with prostate cancer transitioning from Disease-Specific Coverage to Comprehensive Insurance under the Affordable Care Act. J Cancer Policy 2018; 18: 33-39.

Johnson DC, Kwok E, Ahn C, Laviana AA, Rosenthal JT, Litwin MS, Saigal CS. Financial margins for prostate cancer surgery: quantifying the impact of modifiable cost inputs in an episode-based reimbursement model. J Urol 2019; 202: 539-545.

Haymer M, Connor SE, Kwan L, Litwin MS. Modifiable health behaviors among low-income, uninsured men with prostate cancer. Urol Oncol 2020; 38:735.e1-735.e8. Chamie K, Connor SE, Maliski SL, Fink A, Kwan L, Litwin MS. Prostate cancer survivorship: lessons from caring for the uninsured. Urol Oncol 2012; 30: 102-08.

Yiee J, Chang L, Kaplan A, Kwan L, Chung P, Litwin MS. Patterns of care in testicular torsion: influence of hospital transfer on testicular outcomes. J Ped Urol 2013; 9: 713-720.

Scales CD, Hanley LM, Dick A, Setodji C, Saigal CS, Litwin MS. The impact of unplanned post-procedure visits in the management of patients with urinary stones. Surgery 2014; 155: 769-765.

Bergman J, Saigal C, Litwin MS. Service intensity and physician income: conclusions from Medicare's physician data release. JAMA Int Med 2015; 175: 297-299.

Scales CD, Bergman J, Carter S, Jack G, Saigal C, Litwin MS. Quality of acute care for patients with kidney stones in the United States. Urology 2015; 86: 914-921.

Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer. JAMA 2017; 317: 2532-2542.

Nabhani J, Vargas GB, Kwan L, Connor SE, Fink A, Maliski SL, Litwin MS. The experienceof low-income men with prostate cancer transitioning from Disease-Specific Coverage to Comprehensive Insurance under the Affordable Care Act. J Cancer Policy 2018; 18: 33-39.

Johnson DC, Kwok E, Ahn C, Laviana AA, Rosenthal JT, Litwin MS, Saigal CS. Financial margins for prostate cancer surgery: quantifying the impact of modifiable cost inputs in an episode-based reimbursement model. J Urol 2019; 202: 539-545.

Haymer M, Connor SE, Kwan L, Litwin MS. Modifiable health behaviors among low-income, uninsured men with prostate cancer. Urol Oncol 2020; 38:735.e1-735.e8.